Muscle Atrophy: Clinical Trials

4 trials for Muscle Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 withdrawn. 4 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Unknown 2, Completed 1, Withdrawn 1
Phase 22Unknown 1, Withdrawn 1

Follow Muscle Atrophy: new trials by email Literature Review of Muscle Atrophy trials Research Report on Muscle Atrophy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study
Aveed 750 MG in 3 ML IM Injection, Normal Saline 3 ML IM Injection - Muscle Atrophy, Surgery
Phase 2 / Phase 3UnknownThe Stone Research Foundation for Sports Medicine and Arthritis152020-05-082021-08-31
Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit
beta-hydroxy-beta-methylbutyrate, Placebo, Vital HP® - Muscle Atrophy
Phase 2 / Phase 3WithdrawnMassachusetts General Hospital2017-01-012021-05-05
Systemic Hormones and Muscle Protein Synthesis
Sustanon 250, Zoladex, Placebo - Sarcopenia, Muscle Hypotrophy
Phase 3UnknownUniversity of Nottingham342016-12-152019-02-26
Testosterone Administration and ACL Reconstruction in Men
Testosterone, Placebo - Muscle Atrophy, ACL Reconstruction
Phase 3CompletedUniversity of Southern California142012-04-012022-03-02

Narrower conditions

Muscular Atrophy (4)  ·  Wounds and Injuries (2)  ·  Critical Illness (1)  ·  Disease (1)  ·  Hypertrophy (1)  ·  Knee Injuries (1)  ·  Osteoarthritis (1)  ·  Sarcopenia (1)

Broader conditions

Atrophy (4)  ·  Nervous System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Neuromuscular Manifestations (4)  ·  Pathological Conditions, Anatomical (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Pathologic Processes (2)  ·  Arthritis (1)  ·  Disease Attributes (1)  ·  Joint Diseases (1)  ·  Leg Injuries (1)  ·  Musculoskeletal Diseases (1)  ·  Rheumatic Diseases (1)

Interventions

Sodium Chloride (2)  ·  Testosterone (2)  ·  Gonadotropin-Releasing Hormone (1)  ·  Goserelin (1)  ·  Injections, Intramuscular (1)  ·  Saline Solution (1)  ·  Testosterone Propionate (1)  ·  beta-hydroxyisovaleric acid (1)  ·  testosterone enanthate (1)

Sponsors

Massachusetts General Hospital (1)  ·  The Stone Research Foundation for Sports Medicine and Arthritis (1)  ·  University of Nottingham (1)  ·  University of Southern California (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Mani Vessal, Ph.D. (1)  ·  Nathaniel Szewczyk, Ass. Proff (1)  ·  Philip J Atherton, Professor (1)  ·  Sadeq A. Quraishi, MD,MHA,MMSc (1)  ·  Todd Schroeder, PhD (1)

Results publications

PMID 25481088, PMID 28840147